This $25,000 Life-Extension Test Is Impressing Investors But Not Doctors
- Human Longevity valued at $1.9 billion with new investments
- ‘I don’t like the idea of selling a product by scaring people’
Craig Venter
Photographer: Joshua Lott/AFP via Getty ImagesThis article is for subscribers only.
Craig Venter has got a deal for you. For $25,000, he’ll sell you a complete genome sequence, a full-body MRI scan, a cardio CT scan, bone densitometry, cognitive testing and more, all in the hope of discovering a lurking tumor or brain abnormality -- and nipping it in the bud.
“We’re driving a medical revolution,” says Venter of his latest startup, Human Longevity Inc., or HLI. “We have sequencing that’s better than anybody else in the world. We have the most accurate data.”